retatrutide is it a glp1 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) showing unprecedented results in Retatrutide Weight Loss: A Complete

The recently developed receptor agonists for glucagon-like peptide-1 (GLP-1RAs), stimulate insulin secretion and reduce glycated hemoglobin levels without having side effects such as weight gain and hypoglycemia

GLP-1 drugs (exenatide, liraglutide etc), as well as GIP/GLP-1 hybrid peptides (tirzepatide), are clinically approved for diabetes and/or obesity, with GLP-2 based drugs (teduglutide) approved for the treatment of short bowel syndrome

*P.B.s Medicare Part D plan for medications wont cover Mounjaro due to a federal law passed in 2003 that prohibited Medicare from covering weight management medications because of supposed dangerous side effects

These medications may have both positive and negative effects on the gastrointestinal tract

Ziltzer combine clinical expertise, compassionate care, and the latest advancements in obesity medicine to help patients achieve improved health and sustainable results

Furthermore, chronic GIP-receptor agonism can lead to desensitization and eventual loss of GIP receptor activity, which then mimics antagonism